g****e
发帖数: 1426 | 1 Undervalued biotech pharma is getting attention. Short term 10% return!!
Below is the facts about DSCO I just copied from DSCO yahoo message board:
Facts:
1. one approved device
2. one approved drug
3. $40 million in cash
4. no debts
5. no preferred stocks
6. no warrnts
8. exclusive rights
9. excellent pipeline
10. Newly partnership
11. MAA approval soon
12. New device new drug launch soon
13. Mkt Cap 128 million ???
At 3 times sales, this is already $400 million firm, and that is $10 PPS.
DSCO === Hidden Jem. |
k**********4
发帖数: 16092 | 2 这类startup 折腾一阵然后倒闭的多了去了
【在 g****e 的大作中提到】
: Undervalued biotech pharma is getting attention. Short term 10% return!!
: Below is the facts about DSCO I just copied from DSCO yahoo message board:
: Facts:
: 1. one approved device
: 2. one approved drug
: 3. $40 million in cash
: 4. no debts
: 5. no preferred stocks
: 6. no warrnts
: 8. exclusive rights
|
g****e
发帖数: 1426 | 3 We should respects these startup companies who have gotten FDA approvals.
Nowdays it is very difficult to get OK from FDA, 95% of companies failed
after burned minions $$$. Let's wait and see, time will tell. |
